chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately after the shot, my shoulder became very painful. I noticed that the band-aid from the injection was located very high on my arm, right at the shoulder joint towards the back. My arm stayed painful, and I couldn't sleep. I couldn't move my arm normally. I read that arm pain was a normal side effect, so I waited. After 7-8 days, on April 3, I went to the urgent care for a virtual visit. I was seen by a PA. She had my husband rotate my arm in several ways, and it would move normally except if directly out to the side and up over my head. I couldn't raise my arm past horizontal, and my shoulder was very painful. She recommended Ibuprofen, ice, and movement. I did those things, but my arm still was not able to move normally. It felt stuck when I tried to raise it. I went in on April 30 for an in-person visit with my doctor. She examined my shoulder and recommended physical therapy and that I see an orthopedist. I had some difficulty getting authorizations in place in a timely manner, and eventually was able to see an orthopedist for a virtual visit on June 1. He recommended physical therapy and to call back for an MRI if it doesn't resolve after 6 weeks. I had my first physical therapy appointment with  a clinic on June 8. I am currently doing daily PT and seeing the PT weekly.
5 min after receiving vaccine felt clammy and nauseous  vomited small amt undigested food  brought back to OBS 1 via wheelchair upon arriving to OBS area pt pale in color  transferred self without difficulty to stretcher, VS as noted  pt feeling better once laying on stretcher, awake and alert  pt states has anxiety related to needles   pt given snack and water, tolerated well. denies further symptoms  color improved.  pt repositioned self to dangle at side of bed then standing with no further issues. discharged to exit. VS 0925 hr 66 po 100 bp 134/82    0930 hr 71 po 99 bp 138/73   0935 dangle hr 63 po98 bp 121/74  0940 standing hr 79 po 98bp 124/76
Redness and edema with itching on entire right tricep region. Duration x2 days.
Patient presented to pharmacy 10/23/18 to state shoulder still very sore and having issues with range of motion which started after receiving influenza immunization in pharmacy 10/11/2018.
Sore arm almost immediately. Chills and headache 24 hours later. Positive Covid test about 10 days later. Covid symptoms were mostly gastrointestinal and not too terribly bad. Lasted about a week.
pt recv vax & approx 1mo p/vax devel petechiae;several days later devel a large hematoma on rt cheek;pt adm to hosp & on adm platelet count was found to be 7000;pt currently being treated w/steroids & gamma globulin;
Vomiting, nausea, fever 101.4, chills. Diarrhea, and  headache. Went to ER, had a IV and was given fluids because I was dehydrated and zofran for nausea and toradol for migraine.
Information has been received from a registered nurse, for GARDASIL, a Pregnancy Registry product, concerning a 18 year old female patient who on 06-SEP-2007, was intramuscularly vaccinated with a 0.5 mL first dose of GARDASIL. On 21-MAY-2009, the patient was intramuscularly vaccinated with a 0.5 mL second dose of GARDASIL (Lot# 662300/0100Y). On 05-AUG-2010, the patient was intramuscularly vaccinated with a 0.5 mL third dose of GARDASIL (Lot# 665768/1377Y). There was no concomitant medication. On 05-AUG-2010, after the vaccination, a urine pregnancy test was performed to the patient and the result was positive. It was reported that the patient LMP was on beginning of May 2010, and the estimated date of delivery (EDD) is 05-FEB-2011. It was noted that the patient was intending to terminate the pregnancy. Additional information has been received from the registered nurse who stated that on 10-AUG-2010, in the morning, the patient planned to terminate her pregnancy. The patient told to the registered nurse that she had an appointment scheduled for the termination. The registered nurse reported that she had not confirmed this and that she would probably not see this patient again since they were a walk-in sexually transmitted infection clinic. Follow up information has been received from the registered nurse concerning the female patient with a history of a delivered baby boy on 19-APR-2010 and no birth defects or infant complications in the previous pregnancy who on 05-AUG-2010 was vaccinated with a third dose of GARDASIL (Lot# 665768/1377Y). The nurse reported that on 05-AUG-2010 at 10 weeks from LMP, the patient experienced elective termination. It was unknown if the products of conception were examined and if the fetus was normal. Upon internal review the elective termination was considered to be an other important medical event. No further information is available.
Pt. recieved vaccine greater than 12 hours after drawn up. MD contacted. plans to finish series. No adverse event.
Injection site became inflamed and tender 4hrs post vaccine. Patient spike Temp of 101.2 20 hrs post vaccine, resolved with tylenol. Patient had severe body aches and  chills lasting 12 hrs. Patient became very fatigued for 48hrs with intermittent headaches.
I?ve been feeling ill on and off for 2 months. I had regular menstrual cycles until I got vaccinated and now I?ve missed two months of periods. I?m nauseous, achey, bloated, had mild headache for several weeks, and feel chills/hot/cold at times. The vaccine has taken my health away from me. I was healthy and feeling good until I got vaccinated.
My diverticulitis was triggered 2 weeks after I took the vaccine. The same thing happened with the first. This is a rare occurrence since I do not have problems with it flaring up unless I am extremely dehydrated. So I took some antibiotics and got some electrolytes to make them go away.
Ongoing Headaches, Vertigo (dizziness, lightheaded), and twitching in nose since roughly a week after the first covid19 pfizer vaccine dose. No treatment or imaging, but monitoring and getting check-ups by neurologist.
Left arm feels heavy and sore, unable to lift and painful to move since it was administered.  Ibuprofen recommended.
Pt. reported by phone that she awoke on 7 Aug 05 with pain and swelling at the site of injection aprox. dime size.  2 days following injection, site had a welt 1 and 1/2 inches in diameter with redness. Pt also stated she experienced a low-grade fever (not measured by thermometer).
the vial was initially stored in the refrigerator on 16-feb-2023 and administed on 22-feb-2023; No adverse event; 6 adult patients received expired Bivalent Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (6 adult patients received expired Bivalent Moderna COVID-19 vaccine), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 16-feb-2023 and administed on 22-feb-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (6 adult patients received expired Bivalent Moderna COVID-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 16-feb-2023 and administed on 22-feb-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (6 adult patients received expired Bivalent Moderna COVID-19 vaccine), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 16-feb-2023 and administed on 22-feb-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (6 adult patients received expired Bivalent Moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 16-feb-2023 and administed on 22-feb-2023).    Concomitant medication was not provided.  Pharmacist reported that the dose administered after 30-day Use By Date. The vial was intact carton and size was 2.5 ml. The vial was initially stored in refrigerator on 16-Jan-2023 . The vial did not undergo any temperature excursion. Treatment information was not provided. This case contains information for the 2nd patient out of 6 adult patients as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-717807, US-MODERNATX, INC.-MOD-2023-717810, US-MODERNATX, INC.-MOD-2023-717812, US-MODERNATX, INC.-MOD-2023-717811, US-MODERNATX, INC.-MOD-2023-717809 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-717812:Adult Patient 6 US-MODERNATX, INC.-MOD-2023-717810:Adult Patient 4 US-MODERNATX, INC.-MOD-2023-717811:Adult Patient 5 US-MODERNATX, INC.-MOD-2023-717807:Adult Patient 1 US-MODERNATX, INC.-MOD-2023-717809:Adult Patient 3
Headache; body aches; chills; This is a spontaneous report from a contactable consumer. A 24-year-old male patient received second dose of BNT162B2 (CONMIRATY, Solution for injection, Lot number-EL3247, Expiration date- Unknown), via an unspecified route of administration in left arm on 16Feb2021 at 08:15 AM as single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included Bupropion XL, 2000u Vitamin D in two weeks.Prior to the vaccination, the patient was not diagnosed with COVID-19.Post vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within 4 weeks. The patient previously took first dose of BNT162B2 (CONMIRATY, Solution for injection, Lot number-EL3247, Expiration date- Unknown), via an unspecified route of administration in left arm on 26Jan2021 at 08:15 AM as single dose for COVID-19 immunization.On 16Feb2021 at 07:00 PM the patient experienced Headache, body aches and chills. No treatment was received for the events.The Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from healthcare worker refers to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # L010144, expiry date 24-MAR-2017 and lot # L026410, expiry date 15-FEB-2017 (dose, route and site of administration were not reported). No adverse effects were reported. Temperature excursion was noted at 15.8 Fahrenheit for 37 hours and 51 minutes, there was no previous temperature excursion. Additional information has been requested.
DVT - Left leg. Three separate clots in three different veins.  Placed on Eliquis for 3-6 months.
pt stated after getting her 2nd Pfizer Booster she initially felt flushed, ill and lightheaded.  She waited 30 minutes before leaving the vax location.  She went home and called the clinic back to let them know she was having a reaction to the vaccine and that the lady that gave her the vaccine had left the room and came back in the room before giving  her the shot, so she was concerned on what she was actually given.  Upon getting home she developed severe flu like symptoms.  She became nauseous, had chills and fever, had a headache, ringing in the right ear and diarhea later in the evening.   She was not expecting to feel this bad after not having any issues with the other 3 injections.   The ringing in the ears only lasted one day but the other flu like symptoms lingered around for three days.
Patient had rash on chest and all over back. The rash did not hurt or itch. As of 2/11/2017 the rash was almost gone.
3 inch diameter swelling lt ant thigh @ inject site w/o erythema or induration; lasted 24 hrs; dragging leg while walking;
injection site pain - 24 hours, fatigue - 24 hours , muscle stiffness in legs - 12 hours
Child had painful arm for 2 days 4/21-4/23 & noted (local) swelling - (local 10-15 cm right arm red) & erythema 4/22 - seen in clinic 4/23.  Mom gave BENADRYL, 4/22 PM.
p/vax pt subjective breathing problems; eye swollen; hoarseness; epinephrine given
vomiting & diarrhea for 2 days; skin rash, t103;
HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge; HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge) and PRODUCT STORAGE ERROR (HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022j21a) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2022 at 9:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 10-Feb-2022 at 9:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge) and PRODUCT STORAGE ERROR (HCP administered to 5 patients vaccines after 30 days the vaccines were on the fridge) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided.  Patient received vaccine four days after use by date and stated that patient experienced no adverse side effects from vaccine.  HCP stated that they received a box of vials on 7 Jan 2022. There was one vial which was used after 30 days being in the fridge (30 days were on 6 Feb 2022) and they administered Moderna COVID-19 vaccine to five patients. The vaccines were administered in the pharmacy. On 10 Feb 2022 the patients received the vaccine one hours after first puncture. HCP stated that there was no temperature excursion during the administration of that vial (the vials were in the fridge).  No treatment information was provided.   This case was linked to MOD-2022-480636.
Migraines, lung infection, blood clots, pain in lungs, shortness of breath.
Within minutes after receiving the vaccine, I felt pain in my left arm that spread to my neck on the left side, my back on my left side, and down my lower left arm. Within hours my entire left side hurt. Within hours after that my entire body hurt. That evening, and especially the next day, I had flu-like symptoms: feeling sick, aching all over, tiredness, sleeping. These symptoms lasted 1 to 2 days. When the sick feeling subsided, the pain in my arm remained. The pain has not subsided and has gotten worse, and is still present now after 35 days have passed. My left arm hurts and is weak when I lift things and when I raise my arm, especially straight out away from my body.
Patient stated she had a sore arm right after receiving the vaccine. Later that night, around 9pm, she fell ill- nausea, headache, joint pain, and could not walk. The next day - June 28, 2018 around 9am, patient arrived at the emergency room where her throat closed. BENADRYL and a breathing nebulizer were administered in addition to XANAX and ondansetron. Patient followed up with PCP, Dr. on 7/2/18 at which point no further action or care was taken.
Rash/Hives at injection site and left side of chest, neck and arm; Rash/Hives at injection site and left side of chest, neck and arm; Rash/Hives at injection site and left side of chest, neck and arm; Rash/Hives at injection site and left side of chest, neck and arm; This is a spontaneous report from a non-contactable Nurse reported for a female patient. A 32-years-old female patient (non-pregnant) received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: el1283), via intramuscular route of administration in left arm on 10Jan2021 at 12:30 (at the age of 32-years-old) as single dose for COVID-19 immunisation. Medical history included allergic to latex and morphine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has allergic to latex and morphine. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jan2021 at 12:45, the patient experienced rash, hives at injection site and left side of chest, neck, and arm. The patient did not receive any treatment for the events. The outcome of the events was recovered on unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
A red, hot rash appeared on the left side of my torso as well as all over both of my arms and legs.
FEVER, CHILLS, MYALGIA, FATIGUE, TACHYCARDIA, ITCHING ALL OVER. SYMPTOMS LASTED FOR 36 HOURS.
One week after receiving Booster (#3 shot), I was hospitalized with respiratory distress.
Nothing, the child accidentally got a PEDIARIX and IPV in same day. So she got a double dose of polio vaccine. No reaction occurred. We asked CDC about this and they asked us to report it to you.
Beginning 24 hours post vaccination, generalized muscle aches  and moderate abdominal pain. No nausea, vomiting, or diarrhea. Just abdominal pain.
This spontaneous report was received from a pharmacist referring to unspecified patient of unknown age and gender. Pertinent medical history and concomitant conditions were unspecified. On an unknown date the patient was vaccinated with PNEUMOVAX 23, vial (SDV, MDV OR ADDITIVE) (EA) 25, (dose and route not reported). Concomitant therapies were unspecified. On an unknown date the patient developed unspecified systemic reaction and also unspecified injection site reaction. Treatment for the adverse event and lab diagnostic tests were unspecified. There was no intervention required to prevent the seriousness criteria. There was no significant disability, no hospitalization and event was not life threatening. The outcome of the events was recovered. The causality was unspecified. No PQC reported. The case has been linked with the cases (same reporter link) # 1407USA003898 and 1407USA004448. Additional information has been requested.
Headaches (particular Above and behind eyes, Extreme inflammation of joints,) Particular in lower Extremities Knees, tips, lower back went from being active physically to not doing Activities normal things become much more difficult the sun light in eyes brings on headaches in the eye areas. The inflammation seems to have gotten worse and hasn't resided in 9 months activities come to a crawl cause of the discomfort in joints
This spontaneous report was received from a medical assistant referring to a 30 year old patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 31-MAY-2017, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # N003997 and expiration date 20-OCT-2018 (dose and route of administration were not reported) for prophylaxis. There was no adverse effect or product quality complaint reported. No excursion details had been determined at the time of the report. There was a data logger involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA011654.
28 yo female received SPV (PMC VV03-019-C) and IIV (SKB 2GM7P) on 05 SEP 2017 in preparation for move. She states on Sat 16 SEP (day 11) she experienced increased heart beating sensation "out of my chest" and she noted increased breathing, although not truly SOB. She states on Monday she was shopping and became dizzy and experienced tunnel vision. She noted she had decreased activity tolerance such as climbing the stairs, (although was not working out due to pending move), and a dry cough. Her spouse reminded her of the SPV brochure, so after reviewing the recommendations she made an appointment to be seen on Tuesday. PCP sent her to ER and evaluation demonstrated positive troponins and abnormal EKG (ER reported as "non-scary R prime pattern, cardiologist later stated was WNL; report lost), but normal cardiac echo. She was referred to cardiology who did another echo and they collected lab work. She was discharge on ibuprofen 800 mgs po 3x day. She does recall diarrhea on Sunday 17 SEP which lasted 3-4 days. No nausea, emesis, or nasal stuffiness. She denies ever having an EKG prior to this event. She developed mild chest tightness, c/o palpitations and was placed on colchicine by cardiology on 28 SEP 17. Cardiac MRI, event monitor, repeat troponins, repeat echo WNL. Viral studies not consistent with alternate viral etiology. Symptoms fully resolved on follow-up on 02 NOV 17. 'Troponin was negative, stress test was normal, reaching 12 min, >85% MPHR without limitation.' Per note "Cardiac MR without evidence of acute inflammation or scarring. Stress test today with good exercise tolerance. Troponin is negative today as it was last visit. Patient is clear to exercise at own pace for 6 months. She should have a follow up, per HA with cardiology at 6 months. At that time she will have repeat EKG, troponin and stress test; as patient is moving.
About 2 hours after the vaccine, the person reports that she had a burning stinging sensation to her face, and developed a rash.  She reports this is spread to her chest, and she has some itching and scratching in her throat.  She denies any trouble breathing, she has not had any vomiting or diarrhea.  Person presented to the ED at 2018.   Person took Benadryl at home and was provided prednisone in the Emergency Department.  Person was discharged home.
Patient administered vaccine after 12 hours post punctured; Patient administered the vaccine after 12 hours post punctured and temperature excursion; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after 12 hours post punctured) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered the vaccine after 12 hours post punctured and temperature excursion) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after 12 hours post punctured) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered the vaccine after 12 hours post punctured and temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after 12 hours post punctured) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered the vaccine after 12 hours post punctured and temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vial was initially stored in the refrigerator on 10JAN202.  Maximum or minimum temperatures reached, as applicable (specify temp is in C or F) is Min: 36F, Max: 54.47F Excursion duration was 50 minutes.  No concomitant medication were provided No treatment details were provided